Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kalvista Pharmaceuticals Inc. (KALV)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

118,500 $1,375 0.93%
2.
Ghost Tree Capital

Ken Greenberg And David Kim

315,000 $3,654 +5% 0.92%
3.
Deerfield Management

James E. Flynn

890,668 $10,332 -27% 0.42%
4.
Birchview Capital

Matthew Strobeck

30,000 $348 0.23%
5.
Polar Capital

Brian Ashford-Russell And Tim Woolley

1,403,735 $16,283 +2% 0.14%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$11.87 7,962 Director 10,000 2019-09-27 Filing
$11.90 2,038 Director 2,038 2019-09-26 Filing
$17.13 5,137 Director 124,566 2019-07-29 Filing
$17.13 24,730 Director 1,022,493 2019-07-29 Filing
$16.83 21,942 Director 997,763 2019-07-26 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$18.35 7,355 Officer 82,969 2019-07-22 Filing
$18.65 1,900 Officer 96,734 2019-07-23 Filing
$18.57 1,400 Officer 98,634 2019-07-22 Filing
$17.04 10,000 Officer, Director 248,510 2019-07-15 Filing
$26.79 1,000 Officer 82,969 2019-04-22 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 637,884 $7,399 4.56%
2. 388,766 $4,510 1.73%
3. 376,889 $4,372 1.66%
4. 1,680,000 $19,488 0.64%
5. 33,033 $383 0.37%
News See All